1. Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes
   Nicole E. James et al, 2019, Oncotarget CrossRef
2. Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
   Nicole E. James et al, 2018, Frontiers in Oncology CrossRef
3. Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines
   QINSHENG LU et al, 2016, Oncology Reports CrossRef
4. Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells
   Liancheng Zhu et al, 2016, Oncology Reports CrossRef
5. Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix
   Jennifer R. Ribeiro et al, 2018, Frontiers in Oncology CrossRef
6. Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer?
   Khalid El Bairi et al, 2020, Current Drug Targets CrossRef
7. Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
   Zeba Mueed et al, 2021, Current Chemical Biology CrossRef
8. Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration
   Jing Wang et al, 2019, Cancer Cell International CrossRef
9. Targeting and neutralizing human epididymis protein 4 by novel nanobodies to suppress ovarian cancer cells and attenuate cisplatin resistance
   Jianli Yu et al, 2022, International Journal of Biological Macromolecules CrossRef
10. The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients
    Syamel Muhammad et al, 2023, PLOS ONE CrossRef
11. The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes
    Nicole E. James et al, 2020, Scientific Reports CrossRef
12. The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine
    Cailin O’Connell et al, 2022, International Journal of Molecular Sciences CrossRef
13. Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6
    Nicole E. James et al, 2019, Frontiers in Pharmacology CrossRef
14. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells
    Song Gao et al, 2016, Tumor Biology CrossRef
15. Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study
    Francesco Plotti et al, 2021, Biomedicines CrossRef
16. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    J. R. Ribeiro et al, 2016, Journal of Ovarian Research CrossRef
17. Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis
    Xin Nie et al, 2022, International Immunopharmacology CrossRef
18. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation
    Fengbiao Guo et al, 2020, Cancer Cell International CrossRef
19. Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
    Liancheng Zhu et al, 2016, Oncotarget CrossRef
20. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38 MAPK Pathway
    Jian Gao et al, 2022, Advances in Therapy CrossRef
21. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
    Wei Chen et al, 2020, Journal of Ovarian Research CrossRef
22. Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis
    Emanuela Anastasi et al, 2023, International Journal of Molecular Sciences CrossRef